Protalix BioTherapeutics
PLX
#8199
Rank
C$0.26 B
Marketcap
$3.40
Share price
-8.08%
Change (1 day)
107.31%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): C$7.61 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are C$53.39 Million. a decrease over its 2023 earnings that were of C$16.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 C$7.41 M-55.62%
2023 C$16.7 M-199.05%
2022 -C$16.88 Million-40.38%
2021 -C$28.3 Million-732.31%
2020 C$4.47 M-130.53%
2019 -C$14.66 Million189.85%
2018 -C$5.06 Million-95.29%
2017 -C$0.11 Billion308.12%
2016 -C$26.32 Million-32.37%
2015 -C$38.92 Million10.11%
2014 -C$35.34 Million-7.59%
2013 -C$38.24 Million
2011 -C$44.29 Million-19.39%
2010 -C$54.94 Million20.87%
2009 -C$45.45 Million32.26%
2008 -C$34.37 Million-5.46%
2007 -C$36.35 Million
2004 -C$0.24 Million12.35%
2003 -C$0.21 Million-11.1%
2002 -C$0.24 Million-57.03%
2001 -C$0.55 Million1.03%
2000 -C$0.55 Million-53.22%
1999 -C$1.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$40.88 Million-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.72 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.79 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.41 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel